Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
 
 
Twitter
Facebook
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • FigsFigs
  • RefsRefs
  • CitedCited
  • Article title
  • Abstract
  • Keywords
  • Introduction
  • Materials and methods
    • European
  • Results and discussion
    • As of June 2022, the available vaccines authorized for use in the European Union and the United States are
    • In regard to antiviral medications specifically for the treatment of the infection, there are two products authorized for use in the EU and the US
    • Direct purchase of vaccines from the European Commission
    • Delivery of an antiviral medicinal product for the specific treatment of MPOX
    • Sharp decline in MPOX cases in Europe
    • Possibility of application of Jynneos and TPOXX in Bulgaria, as well as measures taken at the national level
  • Conclusion
  • References
Subscribe to email alerts for current Article's categories
Powered by